27 EU member states, modder or vaccine available
“For 460 million vaccines available in the EU”
Discussing additional vaccine purchases… “More vaccines available for Europeans”
Modenasa logo and the appearance of the Corona 19 vaccine. Photo = Reuters Yonhap News
The European Commission (EU) has approved the conditional sale of a novel coronavirus infection (Corona 19) vaccine developed by the US pharmaceutical company Modena.
Modena vaccine, approved for use in Europe… “We will supply more vaccines”
The EU Commission said on the 6th (hereafter local time) that it has accepted the recommendation of the European Medicines Agency (EMA) to approve modder or Corona 19 vaccines and approve the use of modder or vaccine. Earlier that day, EMA recommended approval for the use of the vaccine for those over the age of 18 at an expert meeting.
As a result, Modena became the second Corona 19 vaccine approved for use in Europe.
The EU’s conditional marketing approval is a process for quickly responding to emergencies threatening public health such as COVID-19. It allows the drug to be sold for one year in 27 Member States and can be renewed annually.
Preparing for the Moder or Corona 19 vaccination. Photo = AP Yonhap News
“We will supply more COVID-19 vaccines for Europeans,” said Urzula Ponderrayen, the head of the EU administration, in a statement. It will secure 160 million doses.” “Modena vaccine will be available between the first and third quarters of this year,” he said.
It seems to start shipping next week… Discussion of additional purchase of Pfizer vaccine
Modena vaccines are expected to be distributed to EU member states as early as next week.
The Associated Press said, “Before the announcement of the EMA today, German Health Minister Jens Schfan said he expects the Modena vaccine to begin spreading to EU member states next week.” Bloomberg also quoted Spane as “there is a possibility that Modena will start shipping within the next week.”
The EU approved the conditional sale of the Pfizer-Bioentech vaccine for the first time on the 21st of last month, and the vaccination began in earnest from the 27th of the same month.
Stella Kyriachides, EU Commissioner for Health, said, “Now, the combination of Pfizer-Bioentech vaccine and Modena vaccine can supply 460 million doses of vaccine in the EU.” “I said.
A nursing home resident in Cologne, Germany, frowns while receiving a novel coronavirus infection (Corona 19) vaccine jointly developed by Pfizer in the United States and Bioentech in Germany. Photo = AP Yonhap News
The EU Commission previously signed a contract to purchase 160 million doses of vaccine with Modena and 300 million doses with Pfizer-Bioentech. Reuters quoted a source, “The EU is discussing with the company to purchase an additional 50 million to 100 million doses of Pfizer-Bioentech vaccine.”
94.1% prevention effect… Analysis of the effect of’mutant virus from UK’
Modena said that the final analysis of its vaccine phase 3 clinical trial showed that it had a preventive effect of 94.1%. On November 30, last year, it applied for approval to the EMA for sale.
Like Pfizer-Bioentech, Modena vaccine was developed using’messenger ribonucleic acid’ (mRNA, messenger RNA) containing the genetic information of the virus. However, unlike Pfizer vaccine, which must be frozen at -70 degrees Celsius, it can be stored at -20 degrees Celsius.
Another analysis suggests that the Modena vaccine will also be effective in the recent spread of the British mutant Corona 19 virus.
Kim Soo-hyun, reporter of Hankyung.com [email protected]